Renal Cancer - Results from #2200

Rapid Segmentation of Renal Tumours to Calculate Volume Using 3D Interpolation. February 19, 2021

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. February 18, 2021

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy. February 18, 2021

BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma. February 17, 2021

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma. February 17, 2021

Clinical Implications of (Pro)renin Receptor (PRR) Expression in Renal Tumours. February 16, 2021

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma. February 16, 2021

Long-Term Survival Outcomes of Cytoreductive Nephrectomy Combined with Targeted Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis. February 15, 2021

Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. February 15, 2021

T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production. February 15, 2021

Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. February 15, 2021

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma February 13, 2021

ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19. February 12, 2021

Nephron sparing surgery for the treatment of renal masses: A single center experience. February 12, 2021

Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. February 11, 2021

Neoadjuvant SAbR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus - Safety Lead-in Results of a Phase II Trial. February 11, 2021

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. February 10, 2021

Prognostic value of lymphocyte-to-monocyte ratio previously determined to surgery in patients with non-metastatic renal cell carcinoma: A systematic review and a prisma-compliant meta-analysis. February 10, 2021

Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review. February 10, 2021

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction. February 9, 2021

Page 111 of 457